Paper Details 
Original Abstract of the Article :
Label="BACKGROUND" NlmCategory="BACKGROUND">Epithelial-to-mesenchymal transition (EMT) encompasses a highly dynamic and complex key process which leads to metastatic progression. In high-grade serous ovarian carcinoma (HG-SOC), endothelin-1 (ET-1)/endothelin A receptor (ET<sub>A</sub>R) signaling pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047299/

データ提供:米国国立医学図書館(NLM)

Endothelin-1 and ZEB1/YAP Signaling: A Complex Dance of Metastasis in Ovarian Cancer

Ovarian cancer, a silent and often aggressive disease, can be likened to a treacherous desert, where tumors spread relentlessly. This study delves into the complex interplay between endothelin-1 (ET-1), ZEB1, and YAP signaling in the progression of high-grade serous ovarian cancer (HG-SOC). Researchers used [研究手法] to explore the role of ET-1/ETAR signaling in promoting epithelial-to-mesenchymal transition (EMT), a key process driving metastasis. The results unravel a complex network of regulatory circuits involved in tumor progression and metastasis.

A Complex Network of Metastasis Drivers

The study reveals that ET-1/ETAR signaling plays a pivotal role in driving EMT and promoting tumor progression. [研究結果] This highlights the importance of understanding these complex signaling pathways and developing targeted therapies to disrupt them and prevent metastasis.

Navigating the Desert of Ovarian Cancer

This study underscores the complexity of ovarian cancer and the need for a multi-pronged approach to treatment. By understanding the intricacies of signaling pathways involved in metastasis, we can develop more effective therapies and improve patient outcomes in the fight against this challenging disease.

Dr. Camel's Conclusion

The journey through the desert of ovarian cancer is fraught with challenges. This study provides crucial insights into the complex interplay between ET-1, ZEB1, and YAP signaling, paving the way for developing targeted therapies to combat this devastating disease.

Date :
  1. Date Completed 2022-04-29
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35477522

DOI: Digital Object Identifier

PMC9047299

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.